FOR DRY MOUTH RELIEF in Sjögren ’ s Patients
نویسنده
چکیده
Members Esen Akpek, MD Richard Brasington, MD, FACR Michael Brennan, DDS, MHS Steven E. Carsons, MD* Nancy L. Carteron, MD, FACR Troy Daniels, DDS, MS* H. Kenneth Fisher, MD, FACP, FCCP Gary Foulks, MD, FACS Theresa Lawrence Ford, MD S. Lance Forstot, MD Philip C. Fox, DDS* Robert I. Fox, MD, PhD, FACP* Tara Mardigan, MS, MPH, RD Austin Mircheff, PhD John Daniel Nelson, MD, FACS Kelly Nichols, OD Athena Papas, DMD, PhD Ann Parke, MD Andres Pinto, DMD Nelson Rhodus, DMD, MPH Vidya Sankar, DMD, MHS Daniel Small, MD, FACP Neil Stahl, MD Frederick B. Vivino, MD, FACR Jeffrey Wilson, MD, FACR
منابع مشابه
Oral mucosal manifestations in primary and secondary Sjögren syndrome and dry mouth syndrome.
INTRODUCTION One of the most important symptoms of Sjögren syndrome is xerostomia. The oral cavity deprived of saliva and its natural lubricative, protective and antibacterial properties is prone to a number of unfavourable consequences. AIM To present the most important lesions on the oral mucosa in primary and secondary Sjögren syndrome and in dry mouth syndrome. MATERIAL AND METHODS The ...
متن کاملDiagnosis and management of Sjögren syndrome.
Sjögren syndrome is a systemic autoimmune disease characterized by dry eyes and dry mouth. Other organ systems are affected in many patients. Sjogren syndrome is classified as primary or secondary. In primary disease, Sjogren syndrome is a solitary process, whereas secondary disease accompanies another autoimmune disease--often rheumatoid arthritis. Sjögren syndrome is a challenging diagnosis, ...
متن کاملTreatment of primary Sjögren syndrome: a systematic review.
CONTEXT A variety of topical and systemic drugs are available to treat primary Sjögren syndrome, although no evidence-based therapeutic guidelines are currently available. OBJECTIVE To summarize evidence on primary Sjögren syndrome drug therapy from randomized controlled trials. DATA SOURCES We searched MEDLINE and EMBASE for articles on drug therapy for primary Sjögren syndrome published b...
متن کاملCevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial.
BACKGROUND Cevimeline hydrochloride is a cholinergic agent with muscarinic agonist activity prominently affecting the M1 and M3 receptors prevalent in exocrine glands. We evaluated the safety and efficacy of cevimeline in the treatment of xerostomia in patients with Sjögren syndrome. METHODS Seventy-five patients with Sjögren syndrome and associated salivary gland dysfunction were enrolled in...
متن کاملThe Importance of Minor Salivary Gland Biopsy in Sjögren Syndrome Diagnosis and the Clinicopathological Correlation.
OBJECTIVE Minor salivary gland biopsy is one of the objective tests used in the diagnosis of Sjögren syndrome. The aim of our study was to compare the clinical and laboratory data of primary and secondary Sjögren syndrome cases with a lymphocyte score 3 and 4 in the minor salivary gland biopsy. MATERIAL AND METHOD Data from a total of 2346 consecutive minor salivary gland biopsies were retros...
متن کامل